{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:52:47Z","timestamp":1760709167868},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Diffuse large cell B-cell lymphoma of the skin is most commonly represented by diffuse large cell variants of primary cutaneous follicle center lymphoma and the leg-type lymphoma. In a minority of cases, the infiltrates are an expression of stage 4 disease of established extracutaneous B-cell lymphoma. We describe 1 female patient 85 years of age with an aggressive form of primary cutaneous B-cell lymphoma manifesting in multiple firm erythematous indurated solid nodules 1\u20132 cm each symmetrically on the face periorbitally and on the upper extremities bilaterally. The tumor was a de novo presentation of this aggressive form of lymphoma. The disease demonstrated an aggressive course with only transient improvement of skin lesions after chemotherapy. Punch biopsy taken from a left arm skin lesion showed a diffuse and nodular large cell lymphocytic infiltrate in the 15\u201320 \u03bcm range exhibiting round to oval nuclei and prominent eosinophilic nucleoli. Phenotypically, the tumor cells were CD10, Bcl-2, Bcl-6, and CD43 positive with a residuum of a follicular dendritic cell network revealed by CD21 staining. There was c-MYC rearrangement and CDKN2A deletion in this sample. The importance in reporting this case is to emphasize that in the context of primary cutaneous B-cell lymphoma, the 9p21 deletion while characteristic of the leg-type lymphoma is not a unique signature of the leg-type lymphoma and is not exclusionary to lymphomas falling under the designation of follicle center lymphoma. As with the leg-type lymphoma, however, this cytogenetic abnormality is a critical determinant to a more aggressive clinical course.<\/jats:p>","DOI":"10.1097\/dad.0000000000000738","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T10:00:07Z","timestamp":1476871207000},"page":"e44-e49","source":"Crossref","is-referenced-by-count":8,"title":["An Aggressive Primary Cutaneous Follicle Center Lymphoma With c-MYC Translocation and CDKN2A (9p21) Deletion: A Case Report and Review of the Literature"],"prefix":"10.1097","volume":"39","author":[{"given":"Hamilton C.","family":"Tsang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia M.","family":"Magro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"876","DOI":"10.5858\/arpa.2012-0195-RA","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations","volume":"136","author":"Hristov","year":"2012","journal-title":"Arch Pathol Lab Med."},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.pai.0000143347.58174.91","article-title":"Primary cutaneous CD30+ large cell B-cell lymphoma: a series of 10 cases","volume":"14","author":"Magro","year":"2006","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/107327481201900308","article-title":"Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management","volume":"19","author":"Sokol","year":"2012","journal-title":"Cancer Control"},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4274\/tjh.2013.0200","article-title":"A case of cutaneous diffuse large B-cell lymphoma","volume":"31","author":"\u00c7etin","year":"2014","journal-title":"Turk J Haematol."},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V95.12.3922","article-title":"Primary cutaneous follicle center cell lymphoma with follicular growth pattern","volume":"95","author":"Cerroni","year":"2000","journal-title":"Blood"},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/DAD.0b013e318267495f","article-title":"Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature","volume":"35","author":"Magro","year":"2013","journal-title":"Am J Dermatopathol."},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1001\/archderm.1996.03890350042008","article-title":"Primary cutaneous large B-cell lymphomas of the legs","volume":"132","author":"Vermeer","year":"1996","journal-title":"Arch Dermatol."},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1200\/JCO.2012.43.5800","article-title":"Double-hit diffuse large B-cell lymphoma","volume":"30","author":"Friedberg","year":"2012","journal-title":"J Clin Oncol"},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.hoc.2008.07.002","article-title":"Diffuse large B-cell lymphoma","volume":"22","author":"Friedberg","year":"2008","journal-title":"Hematol Oncol Clin North Am."},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","article-title":"B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma","volume":"34","author":"Snuderl","year":"2010","journal-title":"Am J Surg Pathol."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/modpathol.2011.147","article-title":"B-cell lymphomas with MYC\/8q24 rearrangements and IGH@BCL2\/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol."},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/asheducation-2011.1.506","article-title":"Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification","volume":"2011","author":"Jaffe","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MOH.0b013e328353bbbd","article-title":"Biology of double-hit B cell lymphomas","volume":"19","author":"Lindsley","year":"2012","journal-title":"Curr Opin Hematol."},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V91.12.4677","article-title":"Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma","volume":"91","author":"Elenitoba-Johnson","year":"1998","journal-title":"Blood"},{"key":"R15-20230908","first-page":"3768","article-title":"WHO-EORTC classi cation for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2009","journal-title":"Hematology"},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/DAD.0b013e31829beaa7","article-title":"Cutaneous double-hit B-cell lymphoma: an aggressive form of B-cell lymphoma with a propensity for cutaneous dissemination","volume":"36","author":"Magro","year":"2014","journal-title":"Am J Dermatopathol."},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/modpathol.2012.178","article-title":"Aggressive B-cell lymphomas: how many categories do we need?","volume":"26","author":"Said","year":"2013","journal-title":"Mod Pathol."},{"key":"R19-20230908","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/10428194.2012.710329","article-title":"An aggressive B-cell lymphoma with rearrangements of MYC and CCND1 genes: a rare subtype of double-hit lymphoma","volume":"54","author":"Durot","year":"2013","journal-title":"Leuk Lymphoma."},{"key":"R20-20230908","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1200\/JCO.2005.02.0842","article-title":"Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma","volume":"24","author":"Dijkman","year":"2006","journal-title":"J Clin Oncol."},{"key":"R21-20230908","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00428-008-0593-x","article-title":"Inactivation of p16 INK4a\/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas","volume":"452","author":"Belaud-Rotureau","year":"2008","journal-title":"Virchows Arch."},{"key":"R22-20230908","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/jid.2008.357","article-title":"Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"129","author":"Senff","year":"2009","journal-title":"J Invest Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000372-201703000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T04:09:56Z","timestamp":1694146196000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201703000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000000738","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}